Cash Flow COSMOS Pharmaceutical Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'26
May'25
May'24
May'23
May'22
May'21
No of Months
12
12
12
12
12
12
Profit Before Tax
44,218.00
42,372.00
33,719.00
32,773.00
33,048.00
38,596.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2,691.00
-3,303.00
9,666.00
13,205.00
-2,432.00
-12,560.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
58,790.00
52,467.00
55,175.00
54,434.00
32,194.00
27,875.00
Cash Flow from Investing Activities
-81,903.00
-55,448.00
-57,329.00
-49,113.00
-43,717.00
-19,381.00
Cash Flow from Financing Activities
19,315.00
7,717.00
8,527.00
3,245.00
-6,222.00
-5,507.00
Net Cash Inflow / Outflow
-3,798.00
4,736.00
6,373.00
8,566.00
-17,745.00
2,987.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of COSMOS Pharmaceutical Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
44218
26277
17,941.00
68.28%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2691
-5957
8,648.00
145.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
58790
47845
10,945.00
22.88%
Cash Flow from Investing Activities
-81903
-22736
-59,167.00
-260.23%
Cash Flow from Financing Activities
19315
-20774
40,089.00
192.98%
Net Cash Inflow / Outflow
-3798
4340
-8,138.00
-187.51%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
5
-5.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'26
YoY Growth in year ended May 2026 is 12.05% vs -4.91% in May 2025
May'26
May'25
Change(%)
Cash Flow from Operating Activities
58,790.00
52,467.00
12.05%
Footer loading
